Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.81
CASM's Cash to Debt is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CASM: 0.81 )
CASM' s 10-Year Cash to Debt Range
Min: 0.07   Max: No Debt
Current: 0.81

Equity to Asset 0.35
CASM's Equity to Asset is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CASM: 0.35 )
CASM' s 10-Year Equity to Asset Range
Min: 0.35   Max: 0.86
Current: 0.35

0.35
0.86
F-Score: 2
Z-Score: -0.59
M-Score: -2.95
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -47.70
CASM's Operating margin (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CASM: -47.70 )
CASM' s 10-Year Operating margin (%) Range
Min: -47.7   Max: 20.86
Current: -47.7

-47.7
20.86
Net-margin (%) -47.28
CASM's Net-margin (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CASM: -47.28 )
CASM' s 10-Year Net-margin (%) Range
Min: -47.28   Max: 12.61
Current: -47.28

-47.28
12.61
ROE (%) -109.94
CASM's ROE (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CASM: -109.94 )
CASM' s 10-Year ROE (%) Range
Min: -109.94   Max: 31.7
Current: -109.94

-109.94
31.7
ROA (%) -57.05
CASM's ROA (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CASM: -57.05 )
CASM' s 10-Year ROA (%) Range
Min: -57.05   Max: 23.45
Current: -57.05

-57.05
23.45
ROC (Joel Greenblatt) (%) -180.57
CASM's ROC (Joel Greenblatt) (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CASM: -180.57 )
CASM' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -180.57   Max: 120.69
Current: -180.57

-180.57
120.69
Revenue Growth (%) -11.10
CASM's Revenue Growth (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CASM: -11.10 )
CASM' s 10-Year Revenue Growth (%) Range
Min: -22.5   Max: 25.4
Current: -11.1

-22.5
25.4
EBITDA Growth (%) 109.30
CASM's EBITDA Growth (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CASM: 109.30 )
CASM' s 10-Year EBITDA Growth (%) Range
Min: -34.1   Max: 109.3
Current: 109.3

-34.1
109.3
EPS Growth (%) 77.70
CASM's EPS Growth (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CASM: 77.70 )
CASM' s 10-Year EPS Growth (%) Range
Min: -37   Max: 136.6
Current: 77.7

-37
136.6
» CASM's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

CASM Guru Trades in Q1 2013

Jim Simons 13,600 sh (unchged)
» More
Q2 2013

CASM Guru Trades in Q2 2013

Jim Simons 12,200 sh (-10.29%)
» More
Q3 2013

CASM Guru Trades in Q3 2013

Jim Simons Sold Out
» More
Q2 2014

CASM Guru Trades in Q2 2014

Jim Simons 12,400 sh (New)
» More
» Details

Insider Trades

Latest Guru Trades with CASM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 1.28
CASM's P/S is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CASM: 1.28 )
CASM' s 10-Year P/S Range
Min: 0.38   Max: 6.14
Current: 1.28

0.38
6.14
Current Ratio 4.08
CASM's Current Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CASM: 4.08 )
CASM' s 10-Year Current Ratio Range
Min: 2.12   Max: 9.01
Current: 4.08

2.12
9.01
Quick Ratio 2.94
CASM's Quick Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CASM: 2.94 )
CASM' s 10-Year Quick Ratio Range
Min: 0.87   Max: 7.36
Current: 2.94

0.87
7.36

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 1.10
CASM's Price/Median PS Value is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CASM: 1.10 )
CASM' s 10-Year Price/Median PS Value Range
Min: 0.18   Max: 3.12
Current: 1.1

0.18
3.12
Earnings Yield (Greenblatt) 0.50
CASM's Earnings Yield (Greenblatt) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CASM: 0.50 )
CASM' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.5   Max: 7.7
Current: 0.5

0.5
7.7
Forward Rate of Return (Yacktman) 26.04
CASM's Forward Rate of Return (Yacktman) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CASM: 26.04 )
CASM' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -2.6   Max: 43.1
Current: 26.04

-2.6
43.1

Business Description

Industry: »
Compare: » details
Traded in other countries:UM1.Germany
CAS Medical Systems, Inc. is a Delaware corporation organized in 1984. It is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products that are vital to patient care. Its products include the FORE-SIGHT Absolute Tissue Oximeter and sensors, and its Traditional Monitoring products which include MAXNIBP blood pressure measurement technology, bedside monitoring products, and neonatal vital signs supplies. These products are designed to provide accurate, non-invasive, biologic measurements that guide clinicians to provide better patient care. The Company reports two categories of revenue within one reportable business unit: Tissue Oximetry Monitoring - includes sales of the Company's FORE-SIGHT Absolute Tissue Oximeter monitors, sensors and accessories; and Traditional Monitoring - includes sales of the Company's traditional vital signs products and services including: (i) sales to Original Equipment Manufacturers ('OEM') of the Company's proprietary non-invasive blood pressure technology (MAXNIBP) for inclusion in the OEM customer's own multi-parameter monitors; (ii) bedside vital signs monitors and accessories incorporating various combinations of measurement parameters for both human and veterinary use such as MAXNIBP non-invasive blood pressure, pulse oximetry, electrocardiography (ECG), temperature, and capnography (CO² measurements); (iii) neonatal intensive care vital signs supplies including electrodes and skin temperature probes; and (iv) service repair. The Company markets its products through hospital, surgery center and outpatient facility, homecare, veterinary and emergency medical distribution channels. The Company competes in the broader medical equipment market for patient monitoring equipment and supplies. Medical products of the type currently being marketed and under development by the Company are subject to regulation under the Food, Drug and Cosmetic Act (the FD&C Act) and numerous acts and amendments such as the Quality System Regulations (QSR), often referred to as Good Manufacturing Practices (GMP's).
» More Articles for CASM

Headlines

Articles On GuruFocus.com
CAS Medical Systems Inc. (CASM) CEO Thomas M Patton buys 20,000 Shares Dec 08 2010 
CAS Medical Systems Inc. Reports Operating Results (10-Q) Nov 10 2010 
CAS Medical Systems Inc. Reports Operating Results (10-Q) Aug 04 2010 
CAS Medical Systems Inc. Reports Operating Results (10-Q) May 05 2010 
CAS Medical Systems Inc. Reports Operating Results (10-Q) Nov 05 2009 
CAS Medical Systems Inc. Reports Operating Results (10-Q) Aug 12 2009 
CAS Medical Systems Inc. Reports Operating Results (10-Q) May 06 2009 

More From Other Websites
Nasdaq stocks posting largest volume increases Aug 19 2014
CAS MEDICAL SYSTEMS INC Financials Aug 19 2014
August 06 CASMED Annonces Second Quarter 2014 Financial Results Aug 06 2014
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition Aug 06 2014
Q2 2014 CAS Medical Systems Inc Earnings Release - Before Market Open Aug 06 2014
CASMED Announces Second Quarter 2014 Financial Results Aug 06 2014
CASMED to Announce Second Quarter 2014 Financial Results and Hold Conference Call on August 6th Jul 29 2014
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Other Events Jul 02 2014
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an... Jun 30 2014
CASMED Secures $10 Million Loan Agreement with GE Capital Healthcare Financial Services Jun 30 2014
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Jun 27 2014
CAS Medical cleared to market Fore-Sight Elite Oximeters in Japan Jun 26 2014
CASMED Receives Regulatory Clearance to Market FORE-SIGHT ELITE(R) Oximeters in Japan Jun 26 2014
CASMED and Century Medical Execute Distribution Agreement for FORE-SIGHT(R) Oximeters in Japan May 29 2014
CASMED to Present at the 3rd Annual Marcum MicroCap Conference May 22 2014
CAS Medical receives FDA approval for Fore-Sight Elite in non-cerebral tissue May 07 2014
CAS MEDICAL SYSTEMS INC Files SEC form 10-Q, Quarterly Report May 02 2014
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition May 01 2014
March 20 CASMED Places 1,000th FORE-SIGHT® Cerebral Oximeter Mar 20 2014
CAS MEDICAL SYSTEMS INC Files SEC form 10-K, Annual Report Mar 19 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide